Analystreport

GSK plc (NYSE: GSK) had its price target lowered by analysts at Morgan Stanley from GBX 1,860 to GBX 1,550.

GSK plc American Depositary Shares (Each representing two Ordinary Shares)  (GSK) 
US:NYSE Investor Relations: gsk.com/en-gb/investors